Rna-regulated fusion proteins and methods of their use
AssigneeCornell University
InventorsSamie R. JAFFREY, Jiahui WU
Life of this patent
Estimating the term…
Abstract
The present disclosure is directed to RNA-regulated fusion proteins comprising a protein of interest and an RNA-regulated destabilization domain. Also disclosed are RNA aptamers that bind specifically to a RNA-regulated destabilization domain. Nucleic acid molecules encoding the RNA-regulated fusion proteins and RNA aptamers and methods of use thereof are also disclosed.
Claims106
A nucleic acid molecule encoding an RNA-regulated fusion protein, said nucleic acid molecule comprising:
- a first nucleic acid sequence encoding a protein of interest and
- a second nucleic acid sequence encoding an RNA-regulated destabilization domain, wherein the second nucleic acid sequence is operably coupled to the first nucleic acid sequence.
A nucleic acid molecule encoding a lentiviral transactivator of transcription (Tar) RNA aptamer sequence.
An RNA-regulated fusion protein comprising a protein of interest and an RNA-regulated destabilization domain.
A molecular complex comprising:
- an RNA-regulated fusion protein comprising
- (i) a protein of interest and
- (ii) an RNA-regulated destabilization domain;
- and
- an RNA aptamer bound specifically to the RNA-regulated destabilization domain.
A method of imaging RNA in a cell, said method comprising:
- providing a first vector encoding an RNA-regulated fusion protein, wherein the RNA-regulated fusion protein comprises a fluorescent protein, a bioluminescent protein, or enzyme fused to an RNA-regulated destabilization domain;
- providing a second vector encoding an RNA molecule comprising (i) an RNA sequence of interest and (ii) an RNA aptamer sequence, where the RNA-regulated destabilization domain specifically binds to the RNA aptamer sequence;
- transfecting the host cell with the first vector and the second vector;
- and
- imaging said transfected cells.
A method of imaging RNA in a cell, said method comprising:
- providing a vector encoding an RNA-regulated fusion protein, wherein the RNA-regulated fusion protein comprises a fluorescent protein, a bioluminescent protein, or enzyme fused to an RNA-regulated destabilization domain;
- transfecting the host cell with the first vector;
- contacting said transfected cell with an RNA molecule comprising (i) an RNA sequence of interest and (ii) an RNA aptamer sequence, where the RNA-regulated destabilization domain specifically binds to the RNA aptamer sequence;
- and
- imaging said contacted cells.
A method of selectively modifying an RNA-binding protein, said method comprising:
- providing a first expression vector encoding a RNA-regulated fusion protein, wherein the RNA-regulated fusion protein comprises an enzyme fused to a RNA-regulated destabilization domain;
- providing a second expression vector encoding (i) a RNA sequence of interest and (ii) an RNA aptamer sequence, wherein the RNA-regulated destabilization domain specifically binds to the RNA aptamer sequence;
- transfecting a host cell with the first and second expression vectors;
- allowing the enzyme to be expressed, wherein the expressed enzyme selectively modifies a protein that binds to the RNA sequence of interest.
A method of regulating expression of an RNA-stabilized protein of interest, said method comprising:
- providing a first vector encoding an RNA-regulated fusion protein, wherein the RNA-regulated fusion protein comprises a protein of interest fused to an RNA-regulated destabilization domain;
- providing a second vector encoding an RNA aptamer sequence, wherein the RNA-regulated destabilization domain specifically binds to the RNA aptamer sequence;
- providing a host cell comprising a functional ubiquitination system;
- transfecting the host cell with the first and second expression vectors;
- and
- expressing the first and second expression vectors within the host cell, wherein said expressing the first and second expression vectors regulates proteomic stability of the RNA-regulated fusion protein;
- wherein, in the absence of any expressed RNA aptamer sequence in the host cell, the RNA-regulated destabilization domain promotes degradation of the RNA-regulated fusion protein by the ubiquitination system;
- and wherein the RNA-regulated fusion protein is stabilized by the expressed RNA aptamer sequence.
A treatment method comprising:
- contacting a cell with an RNA aptamer, wherein upon said contacting, the aptamer interacts with an RNA-regulated destabilization domain fused to a protein of interest in the cell to stabilize the protein of interest in the cell.
Dependencies are inferred from the claim text.